New Drug Offers Hope for Severe Fatty Liver Disease (MASH)
Scientists unveil ION224, an experimental drug targeting MASH, a severe fatty liver disease. Clinical trials show promising improvements in liver health.
Scientists unveil ION224, an experimental drug targeting MASH, a severe fatty liver disease. Clinical trials show promising improvements in liver health.